Elimination of HIV-1-infected cells by broadly neutralizing antibodies
Broadly neutralizing antibodies (bNAbs) are promising as potential therapies targeting HIV-1 but their overall antiviral activity remains to be fully elucidated. Here the authors evaluate the ability of a panel of bNAbs to trigger antibody-dependent cellular cytotoxicity and identify the most effect...
Main Authors: | Timothée Bruel, Florence Guivel-Benhassine, Sonia Amraoui, Marine Malbec, Léa Richard, Katia Bourdic, Daniel Aaron Donahue, Valérie Lorin, Nicoletta Casartelli, Nicolas Noël, Olivier Lambotte, Hugo Mouquet, Olivier Schwartz |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2016-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms10844 |
Similar Items
-
Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells
by: Jérémy Dufloo, et al.
Published: (2022-02-01) -
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
by: Jérémy Dufloo, et al.
Published: (2018-07-01) -
Tetherin restricts productive HIV-1 cell-to-cell transmission.
by: Nicoletta Casartelli, et al.
Published: (2010-06-01) -
Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity
by: Julie Prigent, et al.
Published: (2018-05-01) -
Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants
by: Delphine Planas, et al.
Published: (2024-03-01)